论文部分内容阅读
目的探讨黛力新治疗糖尿病合并焦虑抑郁情绪障碍的疗效及安全性。方法收集符合条件患者66例入组,并随机分两组,均主要采用诺和锐30降糖治疗,治疗组在观察组基础上加用黛力新1片,每早、每午各1次口服,对比两组治疗前后SDS、SAS评分情况、血糖控制情况及胰岛素控制血糖达标时间及胰岛素用量,以及黛力新药物不良反应。结果治疗组抑郁焦虑症状明显有改善、血糖控制更好、血糖达标时间明显比对照组短,且胰岛素用量较对照组少,差异有统计学意义。结论黛力新治疗糖尿病合并焦虑抑郁情绪障碍可以更好得控制血糖,改善情绪异常,减少胰岛素用量,缩短调整胰岛素量的时间,治疗效果更快更经济有效。
Objective To investigate the efficacy and safety of Deanxit in the treatment of diabetic patients with anxiety and depression disorder. Methods Sixty-six eligible patients were enrolled and randomized into two groups. All of them were treated with Novo-Rui 30 hypoglycemic therapy. The treatment group was treated with Dean-aid 1 tablet every morning and every afternoon Oral, comparing the two groups before and after treatment SDS, SAS score, glycemic control and insulin control of blood glucose compliance time and insulin dosage, and Deanxit drug adverse reactions. Results The symptoms of depression and anxiety in the treatment group were significantly improved, the blood glucose control was better, the time of reaching the blood glucose level was significantly shorter than that of the control group, and the dosage of insulin was less than that of the control group. The difference was statistically significant. Conclusion Deanxit treatment of diabetes mellitus and anxiety depression disorder can better control blood sugar, improve mood disorders, reduce insulin dosage, shorten the time to adjust the amount of insulin, the treatment effect faster and more cost-effective.